🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Triple-negative breast carcinoma is characterized by the absence of estroge...
Status
Completed
Location
Kahramanmaraş Sütçü İmam University
Start Date
2018-08-01
Trial ID
NCT06309459
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
The purpose of this study is to determine the effectiveness of a particular...
Status
Completed
Location
The University of Chicago
Start Date
2002-12
Trial ID
NCT00774046
Treatments Being Tested
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867
The study is a multicenter, open-label, randomized controlled clinical stud...
Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-20
Trial ID
NCT04928807
Treatments Being Tested
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2021-07-01
Trial ID
NCT05189730
Treatments Being Tested
This is a multicenter phase II clinical study to explore the efficacy, safe...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-04-30
Trial ID
NCT06869226
Treatments Being Tested
The purpose of this randomized Phase II study is to evaluate and compare th...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-05-01
Trial ID
NCT07554768
Treatments Being Tested
This study is a single-center, prospective, open-label, randomized controll...
Status
Completed
Location
Fourth Hospital of Hebei Medical University
Start Date
2021-09-01
Trial ID
NCT05086627
Treatments Being Tested